PRESS RELEASE published on 07/01/2025 at 07:30, 11 months 18 days ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
PRESS RELEASE published on 07/01/2025 at 07:30, 11 months 18 days ago Informations privilégiées / Autres communiqués Sensorion annonce des données préliminaires positives de la première cohorte de l'essai clinique de Phase 1/2 de thérapie génique Audiogene évaluant le SENS-501 pour traiter une forme spécifique de surdité congénitale Sécurité Thérapie Génique Sensorion Surdité Audiogene
BRIEF published on 05/13/2025 at 07:35, 1 year 1 month ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
BRIEF published on 05/13/2025 at 07:35, 1 year 1 month ago Sensorion annonce l'approbation des résolutions de l'assemblée générale des actionnaires Biotechnologie Thérapie Génique Sensorion Résolutions Des Actionnaires Thérapie De La Perte Auditive
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 1 month ago Informations privilégiées / Autres communiqués Sensorion publie les résultats de l’AGM avec adoption de toutes les résolutions recommandées par le CA. Détails des votes disponibles en ligne Biotechnologie Résultats Assemblée Générale Mixte Sensorion Thérapie Auditive
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 1 month ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
BRIEF published on 05/06/2025 at 07:35, 1 year 1 month ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
BRIEF published on 05/06/2025 at 07:35, 1 year 1 month ago Sensorion présentera à la réunion annuelle de l'ASGCT Thérapie Génique Sensorion Perte Auditive DFNB1A Réunion De L'ASGCT
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 1 month ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 1 month ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence annuelle de l'ASGCT pour présenter ses avancées en thérapie génique et cellulaire pour la surdité. Détails des posters et programme de développement dévoilés Innovation Thérapie Génique ASGCT Sensorion Perte Auditive
Published on 06/19/2026 at 04:30, 5 hours 25 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 8 hours 35 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 8 hours 48 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 9 hours 55 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/19/2026 at 09:47, 7 minutes ago AUSTRIACARD HOLDINGS AG: Publication of Management Board and Supervisory Board Reasoned Statements in relation to DNP’s Voluntary Public Takeover Offer
Published on 06/19/2026 at 09:38, 17 minutes ago AI Creates No Value On Its Own: Klickkonzept Launches New AI Enablement Brand, faive
Published on 06/19/2026 at 09:05, 49 minutes ago Trupeer AI Appoints Former UiPath APAC President & CEO Raghu Subramanian to Accelerate German Enterprise Growth
Published on 06/19/2026 at 09:05, 49 minutes ago DORITOS LOADED UNVEILS HIGH-OCTANE COMMERCIAL STARRING CHEF GORDON RAMSAY AND MERCEDES-AMG PETRONAS F1 DRIVER GEORGE RUSSELL
Published on 06/19/2026 at 08:55, 1 hour ago ALPOU - Groupe POULAILLON - Communiqué mise à disposition de la note d'information et DAI relatif à la société visée
Published on 06/19/2026 at 08:55, 1 hour ago ALPOU - Groupe POULAILLON - Communiqué mise à disposition de la note d'information et DAI relatif à EUGENIE
Published on 06/19/2026 at 08:49, 1 hour 6 minutes ago Groupe DLSI - Evolution de la gouvernance et recomposition du Directoire
Published on 06/18/2026 at 18:00, 15 hours 55 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mai 2026
Published on 06/18/2026 at 18:00, 15 hours 55 minutes ago Outstanding shares and voting rights statement at 31 May 2026
